For those experiencing persistent side effects, alternative GLP-1 receptor agonists or other glucose-lowering therapies may be considered
Weeks 142.5 mg once weekly starting dose (non-therapeutic, for tolerability) Weeks 585 mg once weekly Weeks 9+Increased every 4 weeks as tolerated, up to 15 mg weekly maintenance Safety Important safety information GLP-1 medications can cause nausea, vomiting, diarrhea, constipation, and abdominal discomfort, particularly during dose increases
Its only a matter of time before treatment guidelines tell us to put every patient with established heart disease on Ozempic
I wholeheartedly recommend Faces in Bloom, you won't be disappointed
Aging and Metabolism Research: Investigation of age-related decline in mitochondrial function, changes in L-carnitine tissue concentrations, and potential interventions targeting metabolic aging